Letter to the Editor is absolutely normal. One may hypothesize that the hyperviscosity of SCT carriers could, again, stimulate vasodilation and compensate for the negative effects of the other alterations (reduced red blood cell deformability, leucocyte/platelet activation) on blood flow and tissue oxygenation.
Clearly these hypotheses need to be verified but recent data on the beneficial effects of hyperviscosity on vascular function open a new promising and exciting way in the field of hemorheology and physiology.
